Drug details

Firazyr (icatibant injection for subcutaneous administration)

type of Immunomodulators, Selective Bradykinin B2 Receptor Antagonists

Firazyr (icatibant) is a synthetic peptide indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults over the age of 18. People with HAE can develop rapid swelling of the hands, feet, limbs, face, intestinal tract, voice box, or windpipe, which may result in disfigurement, disability, or death.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• severe dizziness
• swelling of your face, lips, tongue, or throat, and

The following drugs are related to Firazyr, either as a replacement or used together:

• Berinert ([c1 esterase inhibitor (human)] freeze-dried powder)
• Orladeyo (berotralstat capsules)
• Cinryze (c1 esterase inhibitor [human] freeze dried powder)
• Ruconest (c1 esterase inhibitor [recombinant] intravenous injection)
• Kalbitor (ecallantide injection)
• Sajazir (icatibant injection, for subcutaneous use)
• Takhzyro (lanadelumab-flyo injection)